SHAWNA REICH: Open Payments
NPI 1437456050 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 25 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $638 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $208 |
| Amgen Inc. | 5 | $76 |
| Edwards Lifesciences Corporation | 1 | $72 |
| Lilly USA, LLC | 3 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: FARXIGA, SAPIEN 3 Ultra RESILIA, BREZTRI, AIRSUPRA, MOUNJARO, OTEZLA, GEMTESA, WATCHMAN FLX.
Industry payments across AL — which companies pay providers there.
